Trials / Completed
CompletedNCT04653805
Therapeutic Approach of Cardiovascular Risk Factors in T2DM by Gender
Differences of the Cardiovascular Risk Factors Therapeutic Approach in T2DM Population According to Gender
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300,000 (actual)
- Sponsor
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
- Sex
- All
- Age
- 31 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Background: Patients with type 2 diabetes mellitus (T2DM) are at 2- to 4-fold higher risk of cardiovascular mortality compared with non-diabetic subjects. Cardiovascular disease (CVD) is the main cause of death in almost half of diabetic population in Spain. Female patients with T2DM have up to 40% excess risk of CVD compared with men and the causes are still unknown. It is argued that a tight control of cardiovascular risk factors could improve the situation. Hypothesis: The cardiovascular risk factors management in women with T2DM is different than in men with T2DM. Aims: To assess the therapeutic approach of cardiovascular risk factors and the occurrence of cardiovascular events among women in comparison to men with T2DM. Methodology: Observational study based on clinical records of primary health care from T2DM patients in Catalonia (2007-2013). Source: SIDIAP database. Analysis: The two study groups (women and men) will be matched to ensure balance in terms of basal comorbidities and previous cardiovascular disease in order to describe the study group characteristics and to perform a multivariate modeling approach. Applicability and Relevance: This study is intended to serve to identify the points of improvement of the cardiovascular risk factors therapeutic approach in women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Current clinical practice in primary care of patients with type 2 diabetes mellitus |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2020-10-01
- Completion
- 2022-05-01
- First posted
- 2020-12-04
- Last updated
- 2023-03-15
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04653805. Inclusion in this directory is not an endorsement.